PAMP
IMA

Polar Asset Management Partners’s ImageneBio Inc IMA Stock Holding History

Polar Asset Management Partners’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,395
Closed -$812K – 1200
2021
Q1 		$812K Buy
+2,395
New +$820K 0.01% 550

Other funds holding IMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Polar Asset Management Partners's IMA Position: Q2 2021 in Review

Polar Asset Management Partners sold out of ImageneBio Inc (IMA) in Q2 2021, closing a stake of 2,395 shares — an estimated $812K sold.

Polar Asset Management Partners first reported a position in IMA in Q1 2021 and held it in 1 quarter. The position peaked at $812K in Q1 2021. 42 funds tracked by Wall St. Rank hold IMA as of Q2 2021.

  • Polar Asset Management Partners reported no remaining ImageneBio Inc position as of Q2 2021 after selling out during the quarter.
  • Polar Asset Management Partners sold 2,395 ImageneBio Inc shares in Q2 2021, an estimated $812K.
  • Polar Asset Management Partners first reported a position in ImageneBio Inc in Q1 2021 and held it in 1 quarter.
  • Polar Asset Management Partners's ImageneBio Inc position peaked at $812K in Q1 2021.
  • 42 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2021.

Based on Polar Asset Management Partners's 13F filing for Q2 2021, filed 16 Aug 2021.